The haematological effects of ACTH and cortisone on patients with rheumatoid arthritis have been described by Rosenthal and others (1950) , Finch and others (1951) , and Copeman and others (1952) , but more information-is needed.
Material
The present paper describes the haematological changes observed in a further twelve cases of rheumatoid arthritis during hormone therapy of 4 to 8 weeks' duration. All these patients had active polyarthritis of moderate severity associated with fever and increased sedimentation rates. Seven patients were treated with cortisone, the usual dose being 1,000 mg. the first week, 700 mg. the second week, and suflicient cortisone thereafter to maintain the clinical improvement of the first fortnight for a further 4 to 6 weeks. Five patients received ACTH in doses of between 45 and 760 mg. per week, sufficient being given to obtain and maintain clinical improvement (Table I) . Analgesics, purgatives, etc., were allowed as needed and certain cases received iron preparations by mouth. Physiotherapy appropriate to their clinical condition was given. A thirteenth patient was investigated but did not receive hormone therapy.
Methods of Investigation
Before therapy was started, the venous blood and sternal marrow of each patient were investigated by standard methods, mostly as described by Dacie (1950) . Haemoglobin (oxyhaemoglobin) was estimated colorimetrically. Total eosinophil counts were made in a double Fuchs-Rosenthal chamber, using one volume of blood with nine volumes of the modification described by Henneman and others (1949) of Randolph's fluid (Randolph, 1944) . The erythrocyte sedimentation rate (E.S.R.) was measured by the technique of Westergren (1921) . The serum iron was estimated by the method of Tompsett .and McAllister (1949) . Marrow from the manubrium sterni was concentrated (as described by Dacie, 1950) before the films were spread on slides. 500 cells were counted for each myelogram; a further 1,500 cells were counted to determine the eosinophil percentages. Sections were made of small marrow fragments by a modification of the method of White and others (1946) .
After the start of therapy the blood counts and E.S.R.s were taken weekly. Marrow puncture was repeated once or twice during-therapy at intervals which varied from a days to 5 weeks. The serum iron test was repeated in a few cases. Clinical improvement was assessed daily and, in greater detail, weekly. Tables II and III. In ten cases the serum iron varied from 37-135 ,ug. per 100 ml. serum (mean 72,ug.) .
In thirteen cases the erythrocyte sedimentation rate (Westergren) (e) Changes in E.S.R.-All cases treated with cortisone showed a decrease: in one case to 35 mm./l hr, in three cases to between 13 and 20 mm. and in three cases to below 13 mm. From 2 to 6 weeks were necessary for the maximum fall. Of five cases followed after therapy, two remained below their initial figure, two became raised above it, and one almost equalled it.
All cases treated with ACTH showed a decrease: in one case to 24 mm., in one case to 20 mm., and in three cases to below 13 mm. in 1 hour.
Of four cases followed after therapy, two remained below their initial figure and two rose above it. i (f) Changes in Bone Marrow.-These were studied by means of films and sections made from aspirated material, but no total counts were made because of their reported unreliability.
In seven cases treated with cortisone the myeloid series showed no significant change (Table IV,  opposite, and Table VII, overleaf) .
Considered separately, one patient (Case 6) showed a fall in the percentage figures due to a marked erythroid hyperplasia, and another (Case 2) showed a rise which was probably absolute as well as relative, because the percentage figures showed a " shift to the right " and the marrow section showed an increase in myeloid cells.
The total eosinophils showed a fall from 4 12 per cent. to 2-02 per cent. (mean figures), but the change is not significant.
The erythroid series showed no significant change in the series as a whole. Considered separately, two patients (Cases 4 and 6) showed an impressive increase (18-2 to 37-2 per cent. and 12-6 to 37 8 per cent., respectively).
The lymphocytes showed a fall from 7 5 to 4 5 per cent. (mean figures) which is significant at the 0 05 level. 
Insignificant
In five cases treated with ACTH no significant change was found in the myeloid series, total eosinophils, lymphocytes, or erythroid series (Tables  IV and VII) .
One patient (Case 10) showed a myeloid hyperplasia. The total eosinophils fell from 4 12 to 3-43 per cent. (mean figures).
The lymphocytes fell from 7-5 to 5 0 per cent. (mean figures) and three patients (Cases 8, 9 , and 12), showed an erythroid hyperplasia (15 6 to 28 4 per cent., 12 8 to 21 2 per cent., and 8 2 to 21 6 per cent. respectively) which was due mainly to an increase in the more mature normoblasts. The percentage of macronormoblasts increased slightly. The myeloid: erythroid ratio fell from 4 8: I to 3 8 1 and 3 7: I during cortisone and ACTH therapy respectively, a shift in the direction of normality (3*2: 1).
If the cortisone and ACTH series are considered together (Table VII) the fall in the lymphocytes becomes more significant (at the 0 2 level) but the other changes remain insignificant.
The monocytes and their precursors showed a fall towards normal from 3 2 per cent. to I 8 per cent. during cortisone therapy and to I 9 per cent. during ACTH therapy (mean figures). The plasma cells showed no change.
(g) Changes in Gastric Juice.-Not followed.
Discussion and Analysis
The patients were selected for their willingness to co-operate and for severe polyarthritis. Anaemia was ignored in their selection. Thus the degree of anaemia found is not typical of rheumatoid arthritis in general, but only of cases selected for moderate duration and severity of arthritis. All the patients showed considerable improvement cliiiically if enough hormone was given, and it was endeavoured to keep the response constant from patient to patient by variation of the dose rather than to give a standard course of therapy and note the variation in the clinical response.
It is probably for this reason that the haematological variations do not appear to correspond as closely with clinical improvement as was noted by Finch and others (1951) in their hormone treated series, or by Nilsson (1948) II. Effects of Therapy.-During therapy the haemoglobin, red cell count, and packed cell volume rose in six out of seven cases treated with cortisone. At 3 weeks the mean rise of the seven cases was just significant, but about half the gain had been lost by the 8th week. Five cases treated with ACTH showed similar changes at 3 weeks, but the smaller number of cases resulted in a lower degree of significance. It is probable that at least half the gain at 3 weeks was due to alterations in the plasma volume (see Robinson, 1943; Finch and others, 1951; Copeman and others, 1952) . By 8 weeks doses of the hormone were in most cases small or had ceased and the apparent gain in the red cell mass at this time was probably a true one. The reticulocytes showed only a small gain and it seems probable that the large quantaties of blood removed by some investigators may have contributed to the height of the reported subsequent reticulocyte crisis.
Study of the erythroid series in the sternal marrow showed that in five of the twelve patients there was a well-marked erythropoietic response, and it is interesting that the mean initial haemoglobin of these 5 patients (four women and one man) was 1 g. per 100 ml. below the mean initial haemoglobin of the group. The mean haemoglobin of Cases 4, 6, 8, and 9 was 9 8 g. (mean for women, 10 -8 g.). The haemoglobin of Case 12 was 10-3 g. (mean for men, 11 3g.).
No correlation was noted between erythropoiesis and clinical response, probably because the dosage was varied widely to obtain a fairly standard clinical improvement, so that the most anaemic patients would need to respond most vigorously.
A moderate degree of anaemia has been shown to follow several hormone deficiencies which usually responded to treatment with the appropriate hormone (Gordon and Charipper, 1947; Daughaday and others, 1948) . Similarly, in these cases of rheumatoid arthritis, the most anaemic patients reacted the most vigorously to cortisone and ACTH. It is probable that the hormones affected the disease processes which had inhibited normal erythropoiesis, so setting the marrow free to respond appropriately to the state of anaemia.
The similarity of the anaemia in infection and in rheumatoid arthritis has been pointed out by Kuhns and others (1950 Finch and others (1951) . The leucocytosis due to a neutrophilia was seen and was significant. No other change was significant, but in three cases there was an immediate eosinopenia and in three cases the initial eosinophil count was later more than doubled. Three of the five cases treated with ACTH showed an immediate eosinopenia with an " escape" to the original level in all.
The changes in the marrow are of considerable interest, though the smallness of the series limits their scientific value. The myeloid series as a whole showed no significant change after therapy, nor was there any " shift " to the left or right in tlhe mean figures. Two cases showed increased leucopoiesis during therapy. Only three marrows were examined within 48 hours of starting therapy, but none showed the accumulation of mature myeloid cells found in mice by Antopol and others (1951) .
The mean marrow eosinophil percentage showed no significant change, in spite of peripheral eosinopenia, in our combined ACTH and' cortisone series,. thus agreeing with Rosenthal and others (1950) , Finch and others (1951) , and Best and Samter (1951) . The cortisone and ACTH series considered separately showed a change in the mean marrow eosinophils from 4 12 per cent. to 2 02 and 3 43 per cent. respectively.
Both cortisone and ACTH caused a similar and considerable fall in the marrow lymphocytes, which is significant at the 0 02 level for the combined series. This change has not been generally remarked in the human cases, possibly because the lymphocytes of the myelogram are usually considered to come from the blood. The work of Veeneklaas (1938), Blitstein (1945), Yoffey and others (1944-50) strongly suggests that the lymphocyte is also a true marrow cell.
The marrow monocytes fell to 1 * 8 per cent.
during cortisone and to 1 * 9 per cent. during ACTH therapy; this phenomenon also has not been previously described.
No change was observed in the plasma cells, reticulum cells, or megakaryocytes, nor was there any correlation between plasmacytosis and the E.S.R. (Silaz and Kresanek, 1949) .
The E.S.R. fell during therapy in all cases, especially between the 2nd and 6th weeks of therapy;
ANNALS OF THE RH in half of the cases it fell to below 13 mm./l hr. The degree of change indicated the degree of clinical improvement, but interpretation is obviously more difficult since Shock (1951) showed that ACTH reduces the E.S.R. in normal people. Summary (1) The blood, marrow, and gastric juice of thirteen cases of severe rheumatoid arthritis of moderate duration have been examined.
(2) Five cases received ACTH and seven received cortisone in sufficient dosage to obtain and maintain a considerable degree of clinical improvement.
(3) During the period of improvement serial examinations of the blood and marrow were made. The haemoglobin, red cell count, and packed cell volume rose in ten of the twelve cases to a degree significant at a low level, but half the gain had been lost by the 5th to 8th week, presumably on account of changes in the plasma volume caused by the therapy. The reticulocytes showed a small increase. Five of the twelve patients showed a well-marked erythroid response, which did not correspond with increased clinical response, but did correspond with the most severe degrees of anaemia. The response appeared to be due to release from the inhibiting effects of disease rather than a true " stimulation" of the marrow.
(4) Four women showed rises in the serum iron during therapy. Three men who started at a higher level showed no change. None achieved the normal level.
(5) During cortisone therapy there was a significant leucocytosis due to a significant neutrophilia. Changes in the other leucocytes were not significant, but about half the cases showed an immediate eosinopenia or a later eosinophilia. Three out of five cases treated with ACTH showed an immediate eosinopenia with subsequent " escape ". In the marrow, the myeloid series showed no significant change or shift, apart from increased leucopoiesis in two cases. The mean marrow eosinophils fell after cortisone and ACTH therapy, from 4-12 per cent. to 2-02 and 3 43 per cent. respectively. The change is not significant.
(6) ACTH and cortisone caused a significant fall in the marrow lymphocytes. The monocytes also fell, but did not reach significance.
(7)'No change during therapy was noted in the plasma cells, reticulum cells, or megakaryocytes.
(8) The erythrocyte sedimentation rate fell in all cases during therapy, in half of them to less than 13 mm./l hr (Westergren) (4) Chez 4 femmes le chiffre du fer serique a accuse une augmentation, tandis que chez 3 hommes, chez qui ce chiffre avait et plus eleve au commencement, on n'a observe aucune modification. Personne n'a atteint un taux normal.
(5) Pendant la therapie a la cortisone il y a eu une leucocytose signifiante due a une neutrophilie signifiante. Les autres deviations leucocytaires n'ont pas ete signifiantes, mais dans pres de la moitie des cas on a observe une eosinopenie, suivie d'un " echappement ". Dans la moelle, la lignee myeloide n'a accuse aucune modification ni deviation signifiante, a l'exception de deux cas de leucopoyese augmentee. Les eosinophiles de la moelle sont tombes apres le traitement par la cortisone et 1'ACTH de 4,12% a 2,02% et 3,43% respectivement. Cette alteration n'est pas signifiante.
(6) L'ACTH et la cortisone ont provoque une chute signifiante des lymphocytes myeloides. I1 y a eu aussi une diminution des monocytes, pas assez prononcee pour etre signifiante.
(7) Au cours du traitement on n'a pas observe d'alterations en ce qui conceme les plasmocytes, les reticulocytes, et les megacaryocytes.
(8) I1 a eu une diminution de la vitesse de sedimentation dans tous les cas traites; dans la moitie de ces cas elle a ete en dessous de 13 mm. en 1-re heure (Westergren).
Efectos de la ACTH y de la cortisona sobre la anemia de la artritis reumatoide SUMARIO (1) Se ha examinado la sangre, la medula 6sea, y el jugo gastrico en trece casos de artritis reumatoide grave y de duraci6n moderada.
(2) Cinco casos recibieron ACTH y siete cortisona en dosis suficientes para obtener y mantener una mejoria clinica considerable. (3) Durante el periodo de mejoria se ha procedido a series de investigaciones de la sangre y de la medula. En diez de los doce casos las cifras de la hemoglobina, de los eritrocitos, y del volumen corpuscular, aunque siempre bajas, aumentaron de manera estadisticamente significante. La mitad de esta ganancia fue perdida entre la quinta y la octava semana, probablemente a consecuencia de las alteraciones del volumen plasmatico causadas por el tratamiento. El numero de los reticulocitos estuvo algo aumentado. Cinco de los doce enfermos manifestaron una reacci6n eritroide bien acentuada que no correspondia a la intensidad de la mejoria clinica sino a la gran severidad de la anemia. Esta reacci6n pareci6 resultar mas bien de la supresi6n de los efectos inhibidores de la enfermedad que de la autentica " estimulaci6n " medular.
(4) En 4 mujeres las cifras del hierro en el suero aumentaron; en 3 hombres estas cifras, mAs altas al principio, quedaron sin cambiar. En ninguno el hierro alcanz6 valores normales.
(5) Durante el tratamiento con la cortisona se observ6 una leucocitosis significante debida a una neutrofilia significante. Otras desviaciones leucocitarias no tuvieron importancia, pero en cerca de la mitad de los casos hubo una eosinopenia, seguida de " fuga ". En la medula, la serie medular no revel6 alteraciones o desviaciones significantes, a excepcion de la leucopoyesis aumentada en dos casos. Los valores de los eosin6filos bajaron despues del tratamiento con cortisona y con ACTH de 4,12% a 2,02% y 3,43% respectivamente. Estas alteraciones no tienen significancia estadistica.
(6) La ACTH y la cortisona motivaron una baja significante de las cifras de los linfocitos medulares. Las cifras de los monocitos tambien bajaron, sin alcanzar una diferencia significante.
(7) Durante el tratamiento no se observ6 alteraciones en los plasmocitos, reticulocitos, o megacariocitos.
(8) La velocidad de sedimentaci6n durante el tratamiento baj6 en todos los casos, descendiendo debajo de 13 mm./l-ra hora (Westergren) en la mitad de ellos.
